Charles River Laboratories International, Inc.

CRLNYSEHealthcare● Active

$184.35

+$3.01(+1.66%)

Market Cap$8.9B

P/E Ratio—

52W High$228.88

52W Low$140.78

Avg Volume897K

Open$182.80

Beta1.45

Net Income Financials Revenue

Charles River Laboratories International, Inc. (CRL) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

CRL · net income · updated Jun 8, 2026

Core profitability metrics

CRL · net income · margin · TTM · CAGR

Net income was −$144.3M for FY2025 (fiscal year ending 2025-12-27), down 1501.7% year-over-year. Net profit margin was -3.6%. Based on available data, Charles River Laboratories International, Inc. has been profitable since at least 2011.

FY2025 Net Income−$144.3M▼ -1501.7% YoY

Trailing 12M (TTM)−$184.7Mtrailing 4 quarters sum

Net Profit Margin-3.6%−$144.3M ÷ $4.02B

YoY Change-1501.7%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2011

▸ FMP /income-statement · Annual · CRL net income history · CRL profit margin

Annual net income data

CRL · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$144.3M▼ 1501.7%-3.6%$4.02B

FY2024$10.3M▼ 97.8%0.3%$4.05B

FY2023$474.6M▼ 2.4%11.5%$4.13B

FY2022$486.2M▲ +24.4%12.2%$3.98B

FY2021$391.0M▲ +7.3%11.0%$3.54B

Net income vs peers (Healthcare)

CRL vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Charles River Laboratories International, Inc.YOU

CRL

−$144.3M-1501.7%-3.6%

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Charles River Laboratories International, Inc. (CRL) reported net income of −$144.3M for FY2025 (fiscal year ending 2025-12-27), down 1501.7% year-over-year. The net profit margin was -3.6% — meaning the company kept $-0.04 of every dollar of revenue as profit.

Based on available data, Charles River Laboratories International, Inc. has been profitable since at least 2011. Net income reached a peak of $486.2M in FY2022. Data available for 15 fiscal years.

Charles River Laboratories International, Inc.'s net profit margin was -3.6% for FY2025, based on the latest annual results.

Investors sometimes search for "Charles River Laboratories International, Inc. net worth" — the company's market capitalization is a separate figure from CRL net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

CRL net income · 4 questions

Charles River Laboratories International, Inc. is not currently profitable on an annual basis. The company reported a net loss of $144.3M for FY2025.

is CRL profitabledoes CRL make a profitCRL profitabilityCRL profitable company

▸ Source: FMP /income-statement · GAAP · Charles River Laboratories International, Inc. · Charles River Laboratories International, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026